Auxesis MedTech AB
Responsible for prototype manufacturing and production.
Our history
Auxesis Pharma was founded with a clear idea: to develop innovative medicines that treat pain and irritation directly in the skin.
What is today a Swedish pharmaceutical company with in-house production and a growing portfolio began as a research project driven by one question: why are there no effective topical medicines that truly remove skin pain?
The idea that started it all
The starting point was simple. Skin pain arises locally, yet it is often treated systemically. Although acetylsalicylic acid is one of the world’s most widely used pain-relieving substances, there was no stable formulation for the skin. That insight became the spark for years of research.
The goal became to create a topical solution with fast, targeted pain-relieving effect—without affecting the rest of the body—marking a step toward a new generation of innovative medicines.
Years of research
The work began with extensive testing of stability, solubility, and effect. Acetylsalicylic acid breaks down quickly in liquid, and the challenge was to control that process. It required hundreds of iterations and close collaboration between researchers, chemists, and advisors to find the right path forward.
Collaboration with researchers from Karolinska Institutet became an important part of the development. Several early formulation tests were carried out there, laying the foundation for our platform.
After nearly a decade of development, a breakthrough was achieved: a stable, liquid form of acetylsalicylic acid with documented shelf life. That opened the door to topical medicines that were previously not possible.
From idea to company
With the technology in place, the project was transformed into a structured operation. Auxesis Pharma Holding AB (publ) was formed to consolidate patents, trademarks, and long-term strategy. Shortly thereafter, two subsidiaries were established:
Auxesis Animal Care AB
Develops topical treatments for animals.
This structure enables high-quality pharmaceutical development in Sweden with close collaborations and short lead times.
Establishment in Sweden
Development takes place together with specialized formulation experts in Lund and clinical development centers in Uppsala. Our Swedish operations give us control over quality, traceability, and sustainability throughout the value chain.
Our model is built on local presence, long-term partnerships, and continuous work to strengthen our patent platform.
Looking ahead
Our journey continues with the same conviction as at the start: pain in the skin should be treated in the skin. Through innovative medicines and pharmaceutical development in Sweden, we aim to create new, better options for both humans and animals.
Do you want to be part of the journey?